1. EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study
   Baohui Han et al, 2017, Lung Cancer CrossRef
2. Factors associated with efficacy of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer
   Shaohua Cui et al, 2017, Tumour Biol. CrossRef
3. The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)
   Fatima Ardito et al, 2017 CrossRef
4. Differential Expression and Clinical Significance of DNA Methyltransferase 3B (DNMT3B), Phosphatase and Tensin Homolog (PTEN) and Human MutL Homologs 1 (hMLH1) in Endometrial Carcinomas
   Wenting Li et al, 2017, Med Sci Monit CrossRef
5. The prognostic value of neutrophil to lymphocyte and platelet to lymphocyte ratios for patients with lung cancer
   Liqun Wang et al, 2017, Oncol Lett CrossRef
6. Long non-coding RNA KCNQ1 overlapping transcript 1 promotes the progression of esophageal squamous cell carcinoma by adsorbing microRNA-133b
   Haitao Xu et al, 2021 CrossRef
7. Clinicopathologic Features and Molecular Biomarkers as Predictors of Epidermal Growth Factor Receptor Gene Mutation in Non-Small Cell Lung Cancer Patients
   Lanlan Liu et al, 2021, Current Oncology CrossRef
8. Association between squamous cell carcinoma antigen level and EGFR mutation status in Chinese lung adenocarcinoma patients
   Shuying Zhang et al, 2022, Clinical Laboratory Analysis CrossRef
9. Correlation between carcinoembryonic antigen (CEA) expression and EGFR mutations in non-small-cell lung cancer: a meta-analysis
   Tian Gan et al, 2023, Clin Transl Oncol CrossRef